Hsp90 inhibitor induces nuclear translocation of HSF1 predominantly in hippocampal CA1 region
Mol Psychiatry
.
2017 Jul;22(7):935.
doi: 10.1038/mp.2017.125.
Authors
B Wang
1
,
Y Liu
2
,
L Huang
3
,
J Chen
4
,
J J Li
1
,
R Wang
1
,
E Kim
1
,
Y Chen
1
,
C Justicia
5
,
K Sakata
1
,
H Chen
1
,
A Planas
5
,
R S Ostrom
1
,
W Li
4
,
G Yang
3
,
M P McDonald
2
6
,
R Chen
7
,
D H Heck
2
,
F-F Liao
1
Affiliations
1
Department of Pharmacology, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
2
Department of Anatomy &Neurobiology, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
3
Department of Anesthesiology, New York University School of Medicine, New York, NY, USA.
4
Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
5
Department of Brain Ischemia and Neurodegeneration, Institute for Biomedical Research (IIBB-CSIC), Barcelona, Spain.
6
Department of Neurology, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
7
Oncosynergy, Inc, San Francisco, CA, USA.
PMID:
28638149
DOI:
10.1038/mp.2017.125
No abstract available